CasLoc logo
All Cases PTAB Litigations UPC Oppositions

BRECKENRIDGE PHARMACEUTICAL, INC. vs. Novartis AG

Explore the PTAB proceeding IPR2016-01023 filed by BRECKENRIDGE PHARMACEUTICAL, INC. on 2016-05-10. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2016-01023

Filing Date

2016-05-10

Accorded Filing Date

2016-05-10

Institution Decision Date

β€”

Last Modified Date

2022-10-10

Proceeding Type

IPR

Termination Date

2016-10-27

Trial Status

Final Written Decision

Parties & Counsel

Patent Owner / Respondent

Patent Information

1 Patent Involved
Respondent Application Number 08416673
Respondent Patent Number 5665772
Legal Expiration Date
2019-09-09 Expired (Term Ended)
Patent Term Adjustment (PTA) +2176 Days Awarded
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred
Respondent Inventor SYLVAIN COTTENS
Respondent Tech Center TC 1200

Tribunal & APJ Panel Intelligence

Board Intelligence

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1200

Decisions Rendered

2 Total

Proceeding Status

Final Written Decision

Administrative Patent Judges (APJ Panel)

Panel assignment tracked upon institution decision entry

Board Decisions & Rulings (2)

Termination 2016-10-27
Joined with IPR2016-00084 per Motion (Paper 20)
37 CFR 42.122, 37 CFR 42.72, 35 USC 315
Termination 2016-10-27
Termination Decision Document
35 U.S.C. Trial Decision

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 5 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts 4 proceedings
πŸ›οΈ
USPTO PTAB Trials 4 proceedings
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (5): GB πŸ‡ΊπŸ‡Έ US 🌐 PCT
Parallel Proceedings Across Jurisdictions (8 found):
PTAB: 4 U.S. Courts: 4
USPTO PTAB Trial 2016-05-26
IPR2016-01103

Breckenridge Pharmaceutical, Inc. v. Novartis AG

Asserted Patent
Status: Institution Denied
USPTO PTAB Trial 2016-05-26
IPR2016-01102

Roxane Laboratories, Inc. et al. v. Novartis AG

Asserted Patent
Status: Final Written Decision
USPTO PTAB Trial 2016-05-17
IPR2016-01059

Par Pharmaceutical, Inc. et al. v. Novartis AG

Asserted Patent
Status: Institution Denied
USPTO PTAB Trial 2015-10-26
IPR2016-00084

Par Pharmaceutical, Inc. et al. v. Novartis AG

Asserted Patent
Status: Final Written Decision
U.S. District Court 2017-04-07
1:17-cv-00389

Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc.

Asserted Patent
Status: DED
U.S. District Court 2016-06-13
1:16-cv-00431

Novartis Pharmaceuticals Corporation v. Breckenridge Pharmaceutical Inc.

Asserted Patent
Status: DED
U.S. District Court 2014-10-10
1:14-cv-01289

Novartis Pharmaceuticals Corporation v. Par Pharmaceutical Inc.

Asserted Patent
Status: DED
U.S. District Court 2014-08-13
1:14-cv-01043

Novartis Pharmaceuticals Corporation v. Breckenridge Pharmaceutical Inc.

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Proceeding Documents

75
22

Final Written Decision (IPR2016-00084) Paper

2018-01-11 FILING PARTY: BOARD
20

Joined with IPR2016-00084 per Motion (Paper 20) Paper

2016-10-27 FILING PARTY: BOARD
21

Termination Decision Document Paper

2016-10-27 FILING PARTY: BOARD
2401

Ex. 2401 Exhibits

2016-07-29 FILING PARTY: PATENT OWN
2404

Ex. 2404 Exhibits

2016-07-29 FILING PARTY: PATENT OWN

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc